Compare NCNA & ELAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NCNA | ELAB |
|---|---|---|
| Founded | 1997 | 2020 |
| Country | United Kingdom | United States |
| Employees | N/A | 34 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 9.6M |
| IPO Year | 2017 | N/A |
| Metric | NCNA | ELAB |
|---|---|---|
| Price | $1.97 | $1.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.0K | ★ 720.6K |
| Earning Date | 06-01-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.03 | $0.66 |
| 52 Week High | $10.00 | $15.00 |
| Indicator | NCNA | ELAB |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 37.03 |
| Support Level | $1.83 | $1.25 |
| Resistance Level | $2.28 | $1.97 |
| Average True Range (ATR) | 0.15 | 0.17 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 12.50 | 9.52 |
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.
PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.